Magnetic resonance imaging findings of pure prostatic ductal adenocarcinomas: a case series.
Cystic component
Distribution
Ductal adenocarcinoma
Magnetic resonance imaging
Periurethral
Prostate
Journal
Abdominal radiology (New York)
ISSN: 2366-0058
Titre abrégé: Abdom Radiol (NY)
Pays: United States
ID NLM: 101674571
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
received:
23
12
2021
accepted:
14
02
2022
revised:
10
02
2022
pubmed:
1
3
2022
medline:
18
5
2022
entrez:
28
2
2022
Statut:
ppublish
Résumé
This study aimed to investigate the characteristics of magnetic resonance imaging (MRI) findings in pure prostatic ductal adenocarcinoma. From January 2009 to February 2020, seven patients who were diagnosed with pure prostatic ductal adenocarcinoma and had a referable preoperative MRI scan were included in the study. We evaluated the following MRI findings for each tumor: size, location, presence of multi-cystic component, and apparent diffusion coefficient (ADC) value. The median maximum diameter of the tumors was 22 mm (range 19-70 mm). Regarding transverse distribution, five tumors were located in the periurethral area and two were located peripherally apart from the urethra. Two of the seven tumors had cystic components. The median ADC value of the tumors was 0.754 × 10 The non-cystic mass with periurethral distribution (type II) and multi-cystic mass (type III) may be characteristic features that differentiate pure ductal adenocarcinoma from ordinary acinar adenocarcinoma on MRI.
Identifiants
pubmed: 35226124
doi: 10.1007/s00261-022-03454-z
pii: 10.1007/s00261-022-03454-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1929-1938Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Dube VE, Farrow GM, Greene LF (1973) Prostatic adenocarcinoma of ductal origin. Cancer 32:402–409. https://doi.org/10.1002/1097-0142(197308)32:2<402::aid-cncr2820320218>3.0.co;2-q
doi: 10.1002/1097-0142(197308)32:2<402::aid-cncr2820320218>3.0.co;2-q
pubmed: 4124700
Humphrey PA (2012) Histological variants of prostatic carcinoma and their significance. Histopathology 60:59–74. https://doi.org/10.1111/j.1365-2559.2011.04039.x
doi: 10.1111/j.1365-2559.2011.04039.x
pubmed: 22212078
Bostwick DG, Kindrachuk RW, Rouse RV (1985) Prostatic adenocarcinoma with endometrioid features. Clinical, pathologic, and ultrastructural findings. Am J Surg Pathol 9:595–609. https://doi.org/10.1097/00000478-198508000-00004
doi: 10.1097/00000478-198508000-00004
pubmed: 4091189
Epstein JI, Woodruff JM (1986) Adenocarcinoma of the prostate with endometrioid features. A light microscopic and immunohistochemical study of ten cases. Cancer 57:111–119. https://doi.org/10.1002/1097-0142(19860101)57:1<111::aid-cncr2820570123>3.0.co;2-n
doi: 10.1002/1097-0142(19860101)57:1<111::aid-cncr2820570123>3.0.co;2-n
pubmed: 2416422
Seipel AH, Wiklund F, Wiklund NP, Egevad L (2013) Histopathological features of ductal adenocarcinoma of the prostate in 1,051 radical prostatectomy specimens. Virchows Arch 462:429–436. https://doi.org/10.1007/s00428-013-1385-5
doi: 10.1007/s00428-013-1385-5
pubmed: 23443941
Ranasinha N, Omer A, Philippou Y, Harriss E, Davies L, Chow K, Chetta PM, Erickson A, Rajakumar T, Mills IG, Bryant RJ, Hamdy FC, Murphy DG, Loda M, Hovens CM, Corcoran NM, Verrill C, Lamb AD (2021) Ductal adenocarcinoma of the prostate: a systematic review and meta‐analysis of incidence, presentation, prognosis, and management. BJUI Compass 2:13–23. https://doi.org/10.1002/bco2.60
doi: 10.1002/bco2.60
pubmed: 35474657
pmcid: 8988764
Amin A, Epstein JI (2011) Pathologic stage of prostatic ductal adenocarcinoma at radical prostatectomy: effect of percentage of the ductal component and associated grade of acinar adenocarcinoma. Am J Surg Pathol 35:615–619. https://doi.org/10.1097/PAS.0b013e31820eb25b
doi: 10.1097/PAS.0b013e31820eb25b
pubmed: 21383610
pmcid: 4425125
Brinker DA, Potter SR, Epstein JI (1999) Ductal adenocarcinoma of the prostate diagnosed on needle biopsy: correlation with clinical and radical prostatectomy findings and progression. Am J Surg Pathol 23:1471–1479. https://doi.org/10.1097/00000478-199912000-00004
doi: 10.1097/00000478-199912000-00004
pubmed: 10584700
Morgan TM, Welty CJ, Vakar-Lopez F, Lin DW, Wright JL (2010) Ductal adenocarcinoma of the prostate: increased mortality risk and decreased serum prostate specific antigen. J Urol 184:2303–2307. https://doi.org/10.1016/j.juro.2010.08.017
doi: 10.1016/j.juro.2010.08.017
pubmed: 20952027
pmcid: 3111052
Meeks JJ, Zhao LC, Cashy J, Kundu S (2012) Incidence and outcomes of ductal carcinoma of the prostate in the USA: analysis of data from the Surveillance, Epidemiology, and End Results program. BJU Int 109:831–834. https://doi.org/10.1111/j.1464-410X.2011.10520.x
doi: 10.1111/j.1464-410X.2011.10520.x
pubmed: 21883856
Matsui Y, Sugino Y, Iwamura H, Oka H, Fukuzawa S, Takeuchi H (2002) Ductal adenocarcinoma of the prostate associated with prostatic multilocular cyst. Int J Urol 9:413–415. https://doi.org/10.1046/j.1442-2042.2002.00481.x
doi: 10.1046/j.1442-2042.2002.00481.x
pubmed: 12165027
Yamashita S, Inaba Y, Soma F, Katayama Y (2005) Pure prostatic papillary adenocarcinoma with ductal features. Hinyokika Kiyo 51:207–209
pubmed: 15852679
Henderson-Jackson E, Sexton W, Zhang J, Hakam A, Petrovskyy VS, Bui MM, Chuang ST (2012) Cystic prostatic ductal adenocarcinoma: an unusual presentation and cytological diagnosis. Ann Clin Lab Sci 42:81–88
pubmed: 22371914
Yadav SS, Baghel P, Tomar V, Agarwal N, Dhakad D (2017) Prostatic ductal adenocarcinoma—a rare entity with radiological dilemma demanding endoscopic biopsy. Urology 108:e1–e2. https://doi.org/10.1016/j.urology.2017.07.003
doi: 10.1016/j.urology.2017.07.003
pubmed: 28712887
Jino E, Kinoshita H, Yanishi M, Shimada S, Koito Y, Watanabe A, Sugi M, Koyama T, Matuda T (2020) [Efficacy of neoadjuvant endocrine therapy for prostate ductal carcinoma with large multiple cysts prior to robot-assisted laparoscopic radical prostatectomy]. Hinyokika Kiyo 66:127–130. https://doi.org/10.14989/ActaUrolJap_66_4_127
doi: 10.14989/ActaUrolJap_66_4_127
pubmed: 32483947
Kitajima K, Yamamoto S, Yamasaki T, Kihara T, Kawanaka Y, Komoto H, Kimura N, Hirota S, Yamakado K (2021) MRI finding of prostatic ductal adenocarcinoma. Case Rep Oncol 14:1387–1391. https://doi.org/10.1159/000518531
doi: 10.1159/000518531
pubmed: 34720946
pmcid: 8525265
Li Y, Mongan J, Behr SC, Sud S, Coakley FV, Simko J, Westphalen AC (2016) Beyond prostate adenocarcinoma: Expanding the differential diagnosis in prostate pathologic conditions. Radiographics 36:1055–1075. https://doi.org/10.1148/rg.2016150226
doi: 10.1148/rg.2016150226
pubmed: 27315446
Coffey N, Schieda N, Cron G, Gulavita P, Mai KT, Flood TA (2015) Multi-parametric (mp) MRI of prostatic ductal adenocarcinoma. J Magn Reson Imaging 41:1639–1645. doi: https://doi.org/10.1002/jmri.24694
doi: 10.1002/jmri.24694
pubmed: 25044687
Schieda N, Coffey N, Gulavita P, Al-Dandan O, Shabana W, Flood TA (2014) Prostatic ductal adenocarcinoma: An aggressive tumour variant unrecognized on T2 weighted magnetic resonance imaging (MRI). Eur Radiol 24:1349–1356. https://doi.org/10.1007/s00330-014-3150-9
Tu SM, Lopez A, Leibovici D, Bilen MA, Evliyaoglu F, Aparicio A, Guo CC, Kuban DA, Johnson MM, Pisters LL (2009) Ductal adenocarcinoma of the prostate: clinical features and implications after local therapy. Cancer 115:2872–2880. https://doi.org/10.1002/cncr.24326
doi: 10.1002/cncr.24326
pubmed: 19402048
Erdogdu I, Tuna B, Yorukoglu K, Montironi R (2022) Biomarkers in urinary tract and male genital system carcinomas, ductal adenocarcinoma. In: Sariogle S, Sagol O, Aysal A (eds) Biomarkers in Carcinoma of Unknown Primary, Springer Nature, Berlin pp 276. https://doi.org/10.1007/978-3-030-84432-5
McDermott VG, Meakem TJ, 3rd, Stolpen AH, Schnall MD (1995) Prostatic and periprostatic cysts: findings on MR imaging. AJR Am J Roentgenology 164:123–127. https://doi.org/10.2214/ajr.164.1.7998524
doi: 10.2214/ajr.164.1.7998524
Melicow MM, Pachter MR (1967) Endometrial carcinoma of proxtatic utricle (uterus masculinus). Cancer 20:1715–1722. https://doi: https://doi.org/10.1002/1097-0142(196710)20:10<1715::aid-cncr2820201022>3.0.co;2-e
Shazer RL, Luthringer D, Agus DB, Gross ME (2004) Ductal adenocarcinoma of the prostate. Clin Adv Hematol Oncol 2:393–395; discussion 396.
Bock BJ, Bostwick DG (1999) Does prostatic ductal adenocarcinoma exist? Am J Surg Pathol 23:781–785. https://doi.org/10.1097/00000478-199907000-00005
doi: 10.1097/00000478-199907000-00005
pubmed: 10403300
Chen ME, Johnston DA, Tang K, Babaian RJ, Troncoso P (2000) Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer 89:1800–1809. https://doi.org/10.1002/1097-0142(20001015)89:8<1800::aid-cncr21>3.0.co;2-d
doi: 10.1002/1097-0142(20001015)89:8<1800::aid-cncr21>3.0.co;2-d
pubmed: 11042576
Bouye S, Potiron E, Puech P, Leroy X, Lemaitre L, Villers A (2009) Transition zone and anterior stromal prostate cancers: zone of origin and intraprostatic patterns of spread at histopathology. Prostate 69:105–113. https://doi.org/10.1002/pros.20859
doi: 10.1002/pros.20859
pubmed: 18850578
Ishii J, Ohori M, Scardino P, Tsuboi T, Slawin K, Wheeler (2007) Significance of the craniocaudal distibution of cancer in radical prostatectomy specimens. Int J Urol 14:817–821. https://doi.org/10.1111/j.1442-2042.2007.01836.x
doi: 10.1111/j.1442-2042.2007.01836.x
pubmed: 17760748
Paner GP, Lopez-Beltran A, So JS, Antic T, Tsuzuki T, McKenney JK (2016) Spectrum of cystic epithelial tumors of the prostate: most cystadenocarcinomas are ductal type with intracystic papillary pattern. AM J Surg Pathol 40:886–895. https://doi.org/10.1097/pas.0000000000000618
doi: 10.1097/pas.0000000000000618
pubmed: 26900818
Marcal LP, Surabhi VR, Ramani NS, Katabathina VS, Paspulati RM, Prasad SR (2022) Mesenchymal neoplasms of the prostate and seminal vesicles: Spectrum of disease with radiologic-pathologic correlation. Radiographics 210084. https://doi.org/10.1148/rg.210084
Miyai K, Mikoshi A, Hamabe F, Nakanishi K, Ito K, Tsuda H, Shinmoto H (2019) Histological differences in cancer cells, stroma, and luminal spaces strongly correlate with in vivo MRI-detectability of prostate cancer. Mod Pathol 32:1536–1543. https://doi.org/10.1038/s41379-019-0292-y
doi: 10.1038/s41379-019-0292-y
pubmed: 31175330
Millar EK, Sharma NK, Lessells AM (1996) Ductal (endometrioid) adenocarcinoma of the prostate: a clinicopathological study of 16 cases. Histopathology 29:11–19. https://doi.org/10.1046/j.1365-2559.1996.d01-483.x
doi: 10.1046/j.1365-2559.1996.d01-483.x
pubmed: 8818689
Orihuela E, Green JM (2008) Ductal prostate cancer: contemporary management and outcomes. Urol Oncol 26:368–371. https://doi.org/10.1016/j.urolonc.2007.05.028
doi: 10.1016/j.urolonc.2007.05.028
pubmed: 18367098